04.10.2018 Issue 397

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Round-up
The Top Story in HEOR: Latest Headlines in HEOR:

HealthCombix Founder, CEO Talks Blockchain

Sunday, April 8

HealthCombix Founder and CEO Cyrus Maaghul recently discussed the blockchain experience during a RelentlessHealthValue podcast.

Expanding Medical Affairs Could Boost Trust, Value

Which Modern Pharmacy Practices Will Become Obsolete?

Report: RWE has Limited Use in Managed Care Formulary Decisions

ICER Pilot Program Offers Glimpse into Method

JAMA Article Spotlights Big Data, Machine Learning

Senators Probe Lomustine’s 1400% Price Surge

KAM Metrics: Driving Efficiency, Measuring Success

Pharma Mostly Posts Lower Prices in Q4 of 2017

Journal Interviews Co-Authors of ASCO Pathway Report

Market Access Consultant, North-West England

EMEA Health Economics Leader, Devices | Europe – Flexible location| £100k +

BCBSA Endowed Chair

Pricing and Market Access Consultant

Cancer Health Economist and Program Director


Consultant – Clinical Outcomes Assessment

Industry Spotlight

Conferences Webinars

Management in Health (Facilitated)
    April 1l, Virtual

Formulary, Co-Pay and Access Summit
    April 11-12, San Francisco, California

Pharmacoeconomics Short Course
    April 12-13, Bangor, U.K.

10th Edition PHARMACCESS Leaders Forum
    April 17-18, London

Pricing and Profit Optimization Benchmarks Thought Leadership Meeting
    April 17

Improving Quality, Value, and Outcomes with Patient-Reported Outcomes: Proceedings from the AMCP Partnership Forum
    April 11

Exclusive Insights into HEOR and Market Access Salary Survey
    April 18

Innovating With Standardization to Scale VBP Programs
    April 24

Globalization Consulting: Smart Information Products for Global Audiences
    April 25

Creating a Successful Global Value Dossier
    May 9

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
KAM Metrics: Driving Efficiency, Measuring Success

Biosimilars: E.U. Payer Perspectives

MSL Teams: Field Force Size and Structure

Market Access Impact: Type 2 Diabetes Mellitus (Injectables) (US) 2017

Market Access Impact: Type 2 Diabetes Mellitus (Orals) (US) 2017

Market Access Impact: Rheumatoid Arthritis (US) 2017

Blockchain-enabled Genomic Data Sharing and Analysis Platform

Reforming Biopharmaceutical Pricing at Home and Abroad

U.S. Presidential Mandate on Value-based Drug Pricing: Moonshot or Wormhole?

The State of Digital Identification and Signatures

Secure Document Workflows in Drug Development

Special Thanks to Our Partners:
Evidence Partners   Evidera    G&J Lee RecruitmentHealthCoreMAPS
      University of FL        Truven    XcendaOM1Parexel
ICON    Jefferson  Dymaxium    Curo
    PharmeritDRG AbacuseMax Health